- New York Abilify Lawsuit Lawyer
- New York Actos Lawsuit Lawyer
- New York Benicar Lawsuit Lawyer
- New York Invokana Lawsuit Lawyer
- New York Januvia Lawsuit Lawyer
- New York Onglyza and Kombiglyze XR Lawsuit Lawyer
- New York Opioids Lawsuit Lawyer
- New York Pradaxa Lawsuit Lawyer
- New York Risperdal Lawsuit Lawyer
- New York Talcum Powder Lawsuit Lawyer
- New York Taxotere Lawsuit Lawyer
- New York Victoza Lawsuit Lawyer
- New York Vioxx Lawsuit Lawyer
- New York Xarelto Lawsuit Lawyer
- New York Zostavax Lawsuit Lawyer
- MAIN Defective Drugs & Devices
New York Januvia Lawsuit Lawyer
Januvia is a drug prescribed to help patients with type-2 diabetes. With the increase in the number of Americans that have diabetes, drugs like Januvia have become incredibly popular.
Most diabetics manage their condition with a combination of diet, exercise, and drugs. Unfortunately, patients taking Januvia began reporting side effects including serious ones such as pancreatic cancer and pancreatitis.
Side Effects of Januvia:
- Kidney failure
- Necrotizing pancreatitis
- Hemorrhagic pancreatitis
- Thyroid cancer
- Acute renal failure
- Blood vessel inflammation under the skin
- Severe abdominal pain
- Severe back pain
- Pancreatic duct metaplasia
- Throat irritation
- Acute sinus/nose/throat infection
- Low blood sugar
- Potentially fatal allergy reaction
- Stevens-Johnson syndrome – severe skin reaction
- Joint pain
- Muscle pain
- Stomach cramps
- Abnormal liver function tests
At Sobo & Sobo we understand that when you take a drug that you believe is helping to manage your diabetes only to find out that the drug is making you sick, you are overwhelmed and angry. There is nothing worse than relying on what a drug manufacturer promises, trusting that the drug was deemed safe, and then developing cancer. Sobo & Sobo L.L.P. are leaders in personal injury law, have won injury settlements for thousands of New York victims and we are here to help you.
More About Januvia
Januvia (sitagliptin) and Janumet are referred to as incretin mimetics, were formulated by Merck & CO., to help patients with type-2 diabetes. Approved in October 2006, they were the first in a new class of diabetic medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. Janumet combines Januvia and metformin for diabetics who cannot control their diabetes with just one drug. These drugs are specifically designed to boost the production of insulin by the pancreas.
Symptoms Reported, Studies Conducted
Patients who had been prescribed Januvia and Janumet began taking these drugs and later started suffering from serious side effects. A number of patients developed pancreatic cancer and pancreatitis.
As the number of cases of pancreatic cancer and pancreatitis reported increased, a few research studies were conducted. Several studies reached the conclusion that Januvia and Janumet could increase the risk of pancreatitis and pancreatic cancer. As a result, the U.S. Food and Drug Administration (FDA), on two occasions, warned patients and physicians about these potential serious side effects.
In 2009, the FDA warned that taking these drugs could increase the risk of developing an inflamed pancreas. This particular warning was issued after post-marketing report showed that 88 patients taking Januvia and/or Janumet developed acute pancreatitis. Although this warning was added to the drugs’ labels it wasn’t until 2013 that a greater fear emerged: that incretin mimetics may well be linked with an increased risk of pancreatic cancer. This was a serious concern as pancreatic cancer is the deadliest form of cancer and almost 96 percent of those diagnosed do not live longer than five years after that diagnosis.
Despite clear signs about serious side effects and harm these two drugs caused, Merck has allegedly failed to adequately research these potential health issues or issue warnings about the risk of pancreatic cancer.
Your Rights Under The Law
Product liability law allows consumers harmed by dangerous or defective drugs to hold drug manufacturers liable for the harm the drug caused them. Such lawsuits not only compensate victims, they raise public awareness about defective and dangerous products.
Common claims made by plaintiffs in product liability law:
- The manufacturer failed to warn physicians about a known side effect
- The manufacturer failed to warn consumers about a known side effect
- The manufacturer defectively designed the drug making it unsafe for consumers
- The manufacturer breached product warranties by selling and marketing a defective drug
- The manufacturer failed to conduct any adequate safety tests to make sure consumers’ health and well being were protected.
Claims specifically made by plaintiffs who have taken Januvia:
- The manufacturer failed to advise doctors to monitor patients for the first indications of changes to the pancreas, which may have helped to pinpoint chronic asymptomatic pancreatitis – a pre-cursor to cancer
- The manufacturer failed to recall Januvia when it became clear the drug’s risks outweighed the benefits
- The manufacturer’s drug labeling is inadequate and fails to mention the potential risk of pancreatic cancer.
Help For Victims of Defective Drugs
The attorneys at Sobo & Sobo are on a mission to help people. They have over 50 years of experience providing unsurpassed legal services. They understand the difficulty of your situation and want to hear your story. During your initial consultation, we listen to you so we can help you make informed decisions about how to proceed.
Take the time to learn about your legal rights, call Sobo & Sobo at 855-468-7626 as soon as possible if you need help with your defective drug litigation. Our prompt action, in partnership with you, could make a difference in the outcome of your case. We would be honored to hear your story and look forward to taking the next step toward Winning Together.